Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. SECOND AMENDED AND RESTATED LICENSE AGREEMENTLicense Agreement • September 19th, 2018 • Ocular Therapeutix, Inc • Pharmaceutical preparations • Delaware
This Second Amended and Restated License Agreement (“Agreement”) dated as of September 13, 2018 (the “Effective Date”), is by and between Incept LLC (“Incept”), a Delaware Limited Liability Company, with offices located at 1359 Dell Avenue, Campbell, CA 95008 and Ocular Therapeutix, Inc. (“Ocular”), a Delaware corporation with offices located at 15 Crosby Dr, Bedford, MA 01730 (each of Incept and Ocular a “Party” and, collectively, the “Parties” to this Agreement).
